Science ❯ Biochemistry ❯ Pharmacology ❯ Receptor Biology
The deal gives an unnamed international biopharma upfront funding and more than $400 million in potential milestones and royalties while deploying XtalPi’s quantum‑AI and automated DMTA engine to overcome a structurally flexible receptor.
